TRISPECIFIC ANTIBODY TARGETING CD79b, CD20, AND CD3 | Patent Publication Number 20220315663

US 20220315663 A1
Patent Number-
Application Number17702282
Filled DateMar 23, 2022
Priority DateMar 24, 2021
Publication DateOct 6, 2022
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsDanlin YANG
Cassandra L. LOWENSTEIN
Sanjaya SINGH
Anna KUCHNIO
Ulrike PHILIPPAR
Nele VLOEMANS
Rajkumar GANESAN
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.